Journal ArticleOPEN ACCESS

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

  • Kamboj I
  • Chang D
  • Habib A
  • et al.
Blood (2024) 144(Supplement 1) 2411.2-2411.2
DOI: 10.1182/blood-2024-199187
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Kamboj, I., Chang, D., Habib, A., Vegel, A., Struble, E., Shaikh, H., … Ahmed, N. (2024). Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial. Blood, 144(Supplement 1), 2411.2-2411.2. https://doi.org/10.1182/blood-2024-199187

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free